logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9700623 B1

PDFFull Text
Date of Patent:
Jul. 11, 2017

Filed:

Nov. 22, 2012

Pharmaceutical composition used for reducing damage caused by free radicals

Applicant:

Original Biomedicals Co., Ltd, Tainan, TW;

Inventors:

Chia-Hung Chen, New Taipei, TW;

Chau-Hui Wang, New Taipei, TW;

John-Son Lin, Taipei, TW;

Tieh-Hsiung Chiu, Los Angeles, CA (US);

Jing-Yi Chen, Taipei, TW;

Pi-Hung Liao, Kaohsiung, TW;

Chia-Chi Su, Taichung, TW;

Wei-Chuan Liao, Kaohsiung, TW;

Assignee:

ORIGINAL BIOMEDICALS CO., LTD., Tainan, TW;

Attorney:

WPAT, PC

Primary Examiner:

Rachael Bredefeld

Int. Cl.
CPC ...
A61K 47/02 (2006.01); A61K 45/06 (2006.01); A61K 38/06 (2006.01); A61K 31/375 (2006.01); A61K 33/34 (2006.01); A61K 33/30 (2006.01); A61K 33/26 (2006.01); A61K 33/24 (2006.01); A61K 33/06 (2006.01); A61K 31/4045 (2006.01); A61K 31/385 (2006.01); A61K 31/05 (2006.01); A61K 31/355 (2006.01); A61K 31/353 (2006.01); A61K 31/205 (2006.01); A61K 31/198 (2006.01); A61K 31/19 (2006.01); A61K 31/185 (2006.01); A61K 31/122 (2006.01); A61K 31/12 (2006.01); A61K 9/107 (2006.01); A61K 31/661 (2006.01); A61K 47/34 (2017.01);
U.S. Cl.
CPC ...
A61K 47/02 (2013.01); A61K 9/1075 (2013.01); A61K 31/05 (2013.01); A61K 31/12 (2013.01); A61K 31/122 (2013.01); A61K 31/185 (2013.01); A61K 31/19 (2013.01); A61K 31/198 (2013.01); A61K 31/205 (2013.01); A61K 31/353 (2013.01); A61K 31/355 (2013.01); A61K 31/375 (2013.01); A61K 31/385 (2013.01); A61K 31/4045 (2013.01); A61K 31/661 (2013.01); A61K 33/06 (2013.01); A61K 33/24 (2013.01); A61K 33/26 (2013.01); A61K 33/30 (2013.01); A61K 33/34 (2013.01); A61K 38/063 (2013.01); A61K 45/06 (2013.01); A61K 47/34 (2013.01);
Abstract

The present invention features a pharmaceutical composition used for reducing the damage caused by free radicals, which comprises at least a metal or its ions, at least a drug or an antioxidant that is carrier-protected/modified, and a drug carrier. Said carrier helps to preserve the anti-oxidative activity, and hence, prevents the decrease of the effect of the antioxidant against free radicals produced in the environment or body fluids and prolongs protection, and may be used for reducing damage caused by radiation and adverse effects induced by chemotherapeutic drugs.

Find Patent Forward Citations

Loading…